Cleared Traditional

K932049 - STANBIO AST/GOT (LIQUI-UV) TEST SET

K932049 is the FDA 510(k) clearance for STANBIO AST/GOT (LIQUI-UV) TEST SET by Stanbio Laboratory. It is a Class 2 Chemistry device (product code CIT) cleared through the Traditional 510(k) pathway after a 203-day FDA review.

K932049 · Stanbio Laboratory · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1993
Decision
203d
Days
Class 2
Risk

K932049 is an FDA 510(k) clearance for the STANBIO AST/GOT (LIQUI-UV) TEST SET, CAT NO. 9020. Classified as Nadh Oxidation/nad Reduction, Ast/sgot (product code CIT), Class II - Special Controls.

Submitted by Stanbio Laboratory (San Antonio, US). The FDA issued a Cleared decision on November 16, 1993 after a review of 203 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1100 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Stanbio Laboratory devices

Submission Details

510(k) Number K932049 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 27, 1993
Decision Date November 16, 1993
Days to Decision 203 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
115d slower than avg
Panel avg: 88d · This submission: 203d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIT Nadh Oxidation/nad Reduction, Ast/sgot
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIT Nadh Oxidation/nad Reduction, Ast/sgot

All 93
Devices cleared under the same product code (CIT) and FDA review panel - the closest regulatory comparables to K932049.
LIQUID AST (SGOT)REAGENT SET
K941132 · Pointe Scientific, Inc., · May 1994
KODAK EKTACHEM CLINICAL CHEMISTRY SLIDE FOR ASPARATE AMIMOTRANSFERASE
K934413 · Eastman Kodak Company · Apr 1994
ASPARTATE AMINOTRANSFERASE (AST) TEST
K935181 · Em Diagnostic Systems, Inc. · Jan 1994
OLYMPUS ASPARTATE AMINOTRANSFERASE REAGENT
K925155 · Olympus Corp. · Jan 1993
ROCHE REAGENT FOR AST
K924244 · Roche Diagnostic Systems, Inc. · Jan 1993
AST (GOT) - ASPARTATE AMINOTRANSFERASE
K923505 · Randox Laboratories, Ltd. · Nov 1992